
LifeMD LFMD
$ 4.7
-4.08%
Quarterly report 2026-Q1
added 05-06-2026
Country |
|
IPO year |
- |
Industry |
Pharmaceutical retailers |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
45.1 M |
Market Cap[1] |
$ 212 M |
EBITDA (LTM) |
$ -8.28 M |
P/E (LTM) |
- |
P/S (LTM) |
1.0 |
EPS (LTM) |
-0.35 |
Other stocks of industry "Pharmaceutical retailers"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
BOQI International Medical
BIMI
|
- | 6.33 % | $ 5.86 M | Nasdaq Capital Market | ||
|
Аптеки 36.6
APTK
|
- | - | - | MOEX | ||
|
Greenlane Holdings
GNLN
|
$ 3.28 | 6.85 % | $ 24.6 M | Nasdaq Global Market | ||
|
China Jo-Jo Drugstores, Inc.
CJJD
|
- | -5.59 % | $ 49.9 M | Nasdaq Capital Market | ||
|
PetMed Express
PETS
|
$ 1.85 | 0.54 % | $ 38.7 M | Nasdaq Global Select Market,SPB | ||
|
Trxade Group
MEDS
|
- | 4.55 % | $ 5.8 M | Nasdaq Capital Market | ||
|
Rite Aid Corporation
RAD
|
- | - | $ 35.5 M | NYSE | ||
|
Walgreens Boots Alliance
WBA
|
- | - | $ 10.3 B | Nasdaq Global Select Market,SPB | ||
|
111
YI
|
$ 4.89 | 14.25 % | $ 851 M | Nasdaq Global Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.